Kathleen Tregoning - Title: Chief Corporate Affairs Officer at Cerevel Therapeutics Holdings, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Title: Chief Corporate Affairs Officer
Stock Symbol
CERE on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

Kathleen Tregoning - trading volume in the past year for Cerevel Therapeutics Holdings, Inc.

Holdings reported by Kathleen Tregoning for Cerevel Therapeutics Holdings, Inc.

Class Num Shares Value Price $ Report Date Ownership Underlying Class Underlying Amount
Restricted Stock Units 59,171 $2.5 M $42.24 Jan 19, 2024 Direct Common Stock
Common Stock 10,666 $450 K $42.24 Dec 26, 2023 Direct
Stock Option (Right to Buy) 255,082 Dec 26, 2023 Direct Common Stock

Transactions reported by Kathleen Tregoning for Cerevel Therapeutics Holdings, Inc.

Sym Class Transaction % Value $ Price $ Shares Shares After Date Ownership